Effect of gut active carbohydrates on plasma IgG concentrations in piglets and calves

Improving immune status in neonates is crucial to health and production. Gut active carbohydrates (GAC) have been associated with increasing immunoglobin levels and immonucompetence development in mammals. The objective of the following studies was to evaluate whether GAC (mannan-oligosaccharides) applied orally to progeny immediately following parturition, improved blood plasma immunoglobulin (Ig) type G concentrations in piglets and calves. Three trials were conducted comparing control groups with those receiving GAC orally. The first two trials used piglets that were monitored for blood IgG at 2 days of age and for changes in body weight (BW), and the third trial monitored calf IgG from birth to 21 days of age. Piglets in the experimental group received 0.75 g GAC in 10 ml saline at birth and 24 h of age. The calf trial compared the control group against calves that received 22.5 g GAC mixed into 4.5 l of colostrum (to give 5 g/l) in the first 24 h after parturition. Blood serum samples were taken at 2 days post partum in piglets, and at several time points from 6 h to 21 days of age in calves, and were analysed for IgG levels by radial immunodiffusion. In the first piglet trial, significantly higher levels (32%) of IgG were observed for piglets fed GAC (P < 0.001), and in the second, IgG concentration was elevated by 23% (P < 0.01) and BW increased by 9% (P = 0.023) with GAC supplementation. Significant improvements for calves were recorded at all time points in those fed GAC (P < 0.05), with an increase in serum IgG observed after the first day, which was maintained throughout the sampling period, resulting in a difference of 39% at the end of the trial (21 d). These findings form a basis for further studies, which are required to investigate possible modes of action involved in enhancing blood immunoglobulin concentrations in young animals, and the longer-term effects this may have on the development of the immune respons

Lattice dynamics of FeSb2

The lattice dynamics of FeSb2 is investigated by the first-principles DFT calculations and Raman spectroscopy. All Raman and infra-red active phonon modes are properly assigned. The calculated and measured phonon energies are in good agreement except for the B3g symmetry mode. We have observed strong mixing of the Ag symmetry modes, with the intensity exchange in the temperature range between 210 K and 260 K. The Ag modes repulsion increases by doping FeSb2 with Co. There are no signatures of the electron-phonon interaction for these modes

Oral and intestinal dysbiosis in Parkinson's disease.

The suspicion of an origin of Parkinson's disease (PD) at the periphery of the body and the involvement of environmental risk factors in the pathogenesis of PD have directed the attention of the scientific community towards the microbiota. The microbiota represents all the microorganisms residing both in and on a host. It plays an essential role in the physiological functioning of the host. In this article, we review the dysbiosis repeatedly demonstrated in PD and how it influences PD symptoms. Dysbiosis is associated with both motor and non-motor PD symptoms. In animal models, dysbiosis only promotes symptoms in individuals genetically susceptible to Parkinson's disease, suggesting that dysbiosis is a risk factor but not a cause of Parkinson's disease. We also review how dysbiosis contributes to the pathophysiology of PD. Dysbiosis induces numerous and complex metabolic changes, resulting in increased intestinal permeability, local and systemic inflammation, production of bacterial amyloid proteins that promote α-synuclein aggregation, as well as a decrease in short-chain fatty acid-producing bacteria that have anti-inflammatory and neuroprotective potential. In addition, we review how dysbiosis decreases the efficacy of dopaminergic treatments. We then discuss the interest of dysbiosis analysis as a biomarker of Parkinson's disease. Finally, we give an overview of how interventions modulating the gut microbiota such as dietary interventions, pro-biotics, intestinal decontamination and fecal microbiota transplantation could influence the course of PD

Long-term, multiwavelength light curves of ultra-cool dwarfs: I. An interplay of starspots & clouds likely drive the variability of the L3. 5 dwarf 2MASS 0036+ 18

We present multi-telescope, ground-based, multiwavelength optical and near-infrared photometry of the variable L3.5 ultra-cool dwarf 2MASSW J0036159+182110. We present 22 nights of photometry of 2MASSW J0036159+182110, including 7 nights of simultaneous, multiwavelength photometry, spread over ∼120 days allowing us to determine the rotation period of this ultra-cool dwarf to be 3.080 ± 0.001 hr. Our many nights of multiwavelength photometry allow us to observe the evolution, or more specifically the lack thereof, of the light curve over a great many rotation periods. The lack of discernible phase shifts in our multiwavelength photometry, and that the amplitude of variability generally decreases as one moves to longer wavelengths for 2MASSW J0036159+182110, is generally consistent with starspots driving the variability on this ultra-cool dwarf, with starspots that are ∼100 degrees K hotter or cooler than the ∼1700 K photosphere. Also, reasonably thick clouds are required to fit the spectra of 2MASSW J0036159+182110, suggesting there likely exists some complex interplay between the starspots driving the variability of this ultra-cool dwarf and the clouds that appear to envelope this ultra-cool dwarf.https://arxiv.org/pdf/1609.03586.pdfFirst author draf

Decontamination of 16S rRNA gene amplicon sequence datasets based on bacterial load assessment by qPCR

Identification of unexpected taxa in 16S rRNA surveys of low-density microbiota, diluted mock communities and cultures demonstrated that a variable fraction of sequence reads originated from exogenous DNA. The sources of these contaminants are reagents used in DNA extraction, PCR, and next-generation sequencing library preparation, and human (skin, oral and respiratory) microbiota from the investigators

Early growth response gene-2 (Egr-2) regulates the development of B and T cells

The study was supported by Arthritis Research UK. Copyright @ 2011 Li et al.BACKGROUND: Understanding of how transcription factors are involved in lymphocyte development still remains a challenge. It has been shown that Egr-2 deficiency results in impaired NKT cell development and defective positive selection of T cells. Here we investigated the development of T, B and NKT cells in Egr-2 transgenic mice and the roles in the regulation of distinct stages of B and T cell development. METHODS AND FINDINGS: The expression of Egr1, 2 and 3 were analysed at different stages of T and B cell development by RT-PCT and results showed that the expression was strictly regulated at different stages. Forced expression of Egr-2 in CD2+ lymphocytes resulted in a severe reduction of CD4+CD8+ (DP) cells in thymus and pro-B cells in bone marrow, which was associated with reduced expression of Notch1 in ISP thymocytes and Pax5 in pro-B cells, suggesting that retraction of Egr-2 at the ISP and pro-B cell stages is important for the activation of lineage differentiation programs. In contrast to reduction of DP and pro-B cells, Egr-2 enhanced the maturation of DP cells into single positive (SP) T and NKT cells in thymus, and immature B cells into mature B cells in bone marrow. CONCLUSIONS: Our results demonstrate that Egr-2 expressed in restricted stages of lymphocyte development plays a dynamic, but similar role for the development of T, NKT and B cells.This article is provided by the Brunel Open Access publishing fund

Impact and process assessment of the seven CITYLAB implementations

CITYLAB focuses on four axes that call for improvement and intervention: •Highly fragmented last-mile deliveries in city centres •Inefficient deliveries to large freight attractors and public administrations •Urban waste, return trips and recycling •Logistics sprawl Within these axes, the project supports seven implementations that are being tested, evaluated and rolled out. An implementation is defined as the process of preparing, testing and putting into practice a new service or a new way of operating or organising logistics activities. The objective of this report is to present an assessment of the effects and consequences of the implementations as they are conducted. For each case, we summarise the process leading to the application of a specific technical and managerial solution, and present the outcomes. For each implementation, we present •Problem and aim •Description of the solution •Implementation process •Effects and consequences •Challenges ahead •Lessons and generalisation of results This deliverable provides a complete picture of the evolvement of the implementations during the CITYLAB project and final versions of the process and impact assessment